AMG 386 (trebananib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMG 386 (trebananib), covering 2017-02-08 to 2017-11-06. Get the full timeline:
Most recent: Clinical Trial Update: A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function [Phase 1]